You are here

• Home
• Therapy Areas
• Cardiovascular

• A randomized, single-blind, placebo-controlled, phase I study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD1656 compared to placebo in T2DM patients treated with metformin and sulfonylurea

Disease

diabetes mellitus

Drug Name

AZD1656

Generic Name

AZD1656

Sponsor

AstraZeneca

Drug Status

Discontinued

Phase

I

Start Date

Oct 5, 2009

Study Name

D1020C00026

Study Id

D1020C00026

ClinicalTrials.gov ID

NCT00995787

Recruiting Status

Closed

Protocol Status

Not Available

Report

May 25, 2010

• D1020C00026.pdf (146 KB)

Page tools

• Print
• Bookmark this page